Physicians' Academy for Cardiovascular Education

Anacetrapib reduces non-HDL-cholesterolvia reducing PCSK9 and enhancing hepatic remnant clearance

Slides (presentation) - June 18, 2015

Presentation prepared and held by Dr Yanan Wang (Leiden, The Netherlands) in Clinical Breakthroughs: A plethora of new therapeutic targets, Sunday, May 24, 2015 during ISA2015 (Amsterdam, The Netherlands).

To view slides, click on images
2015_ISA_266_ANA_and_lipid_metabolism_YW.pdf (2,4MB)2015_ISA_266_ANA_and_lipid_metabolism_YW.pdf (2,4MB)

The content is aimed for medical professionals. To view this item member registration is needed. Register for free to get unlimited access to our educational resources.

Share this page with your colleagues and friends: